Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
05/2006
05/24/2006EP1658269A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
05/24/2006EP1384477B1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
05/24/2006EP1100492B1 INDOLE sPLA2 INHIBITORS
05/24/2006EP0894786B1 Silver halide color photographic material, phenidone compounds used therefor, and process for preparing the same
05/24/2006DE10347386B4 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories
05/24/2006CN1777597A Indazole having analgesic activity
05/24/2006CN1777590A Indazole derivatives
05/24/2006CN1777589A Heteroarylcarbamoylbenzene derivative
05/24/2006CN1777577A Antibacterial agents
05/24/2006CN1257168C Compound of pyrazole [4,3-c] quinolines and preparation process thereof
05/23/2006US7049343 Nitrogen compounds such as 3-(N'-(2,6-dinitro-4-trifluoro methylphenyl)-N-(3-methoxyphenylhydrazino)propionic acid, used as glycine transport antagonists for prophylaxis of psychological disorders
05/23/2006US7049308 For therapy of inflammatory or painful disorder
05/23/2006US7049307 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
05/23/2006US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.
05/18/2006WO2006052913A1 PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
05/18/2006WO2006052190A1 Indazole sulphonamide derivatives
05/18/2006WO2006052189A1 Nitro indazole derivatives
05/18/2006WO2006051704A1 Imine compound
05/18/2006WO2006051340A1 Novel form of celecoxib
05/18/2006WO2006051143A1 Heterocyclic ligands and the gadolinium (iii) complexes thereof with biomedical applications
05/18/2006WO2006051142A1 1-pyrazolylethyl-1,4,7,10-tetraazacyclododecane-4,7,10-triacetic acids and application of the gadolinium (iii) complexes thereof in clinical diagnosis
05/18/2006WO2006050772A1 Vinylaminopyrazole derivatives as pesticides
05/18/2006WO2005051301A3 Heterocyclic inhibitors of mek and methods of use thereof
05/18/2006US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type
05/18/2006US20060106084 [(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones
05/18/2006US20060106083 N-[6-(3-Methylphenyl)-1H-indazol-3-yl]cyclopropanecarboxamide, for example; useful in therapy as agents against a host of diseases caused by and/or associated to a disregulated protein kinase activity; inflammatory conditions, cancer
05/18/2006US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
05/18/2006US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile
05/18/2006US20060106036 Phenylpyrazole compounds such as 1-(3-cyano-4-neopentyloxyphenyl)pyrazole-4-carboxylic acid and the like for preventing colon cancer and the like, and as an agent for suppressing tumorigenesis
05/18/2006DE102004054666A1 New substituted pyrazol-3-carboxamide derivatives useful to combat harmful plants and for growth regulation of plants
05/18/2006CA2587667A1 Imine compound
05/18/2006CA2586702A1 Vinylaminopyrazole derivatives as pesticides
05/18/2006CA2586375A1 Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
05/18/2006CA2574326A1 Novel form of celecoxib
05/17/2006EP1656383A1 4-biphenyl-substituted 4-substituted pyrazolidin-3,5-diones pesticide agent and/or microbicide and/or herbicide
05/17/2006EP1656382A2 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
05/17/2006EP1656353A1 Gabanergic modulators
05/17/2006EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase
05/17/2006EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
05/17/2006CN1256329C Herbicidal substituted benzoylpyrazoles
05/16/2006US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout
05/16/2006US7045532 ACE-2 modulating compounds and methods of use thereof
05/16/2006CA2244903C Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation
05/11/2006WO2006050035A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents
05/11/2006WO2006050034A1 Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents
05/11/2006WO2006050006A2 ((1h-indazol-3-yl)methyl) phenols and (hydroxyphenyl)(1h-indazol-3-yl) methanones as ligands of the estrogen receptor
05/11/2006WO2006048761A2 Methods for preparing indazole compounds
05/11/2006WO2006048744A1 Methods of preparing indazole compounds
05/11/2006US20060100260 Substituted pyrazoline carboxanilides for use as pesticides
05/11/2006US20060100250 Biphenyl derivatives and their use as fungicides
05/11/2006US20060100248 alleviating vision defects, multiple sclerosis, neurodegenerative diseases, stroke, spinal cord injury, Alzheimer's disease, Parkinson's disease or pain, comprising administering sodium channel modulators comprising pyrazole or indazole derivatives, such as 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole
05/11/2006US20060100196 Substituted amines for the treatment of alzheimer's disease
05/11/2006CA2591313A1 Methods for preparing indazole compounds
05/11/2006CA2586174A1 Methods of preparing indazole compounds
05/11/2006CA2585383A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents
05/11/2006CA2585373A1 Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents
05/10/2006EP1654247A1 Alkynyl aryl carboxamides
05/10/2006EP1653949A2 Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
05/10/2006EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors
05/10/2006CN1771244A Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
05/10/2006CN1255405C Substituted pyrazoles
05/10/2006CN1255384C N-pyrazolylcarboxanilides as fungicides
05/09/2006US7041833 3-step synthesis of pyrazolotriazole couplers and coupler intermediates
05/09/2006US7041687 Indazole compounds useful as protein kinase inhibitors
05/09/2006US7041670 Florfenicol-type antibiotics
05/09/2006US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases
05/09/2006US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer
05/09/2006US7041161 Trisazo dyes for ink jet printing
05/09/2006CA2239489C 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity
05/09/2006CA2238430C Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives
05/04/2006WO2006047528A2 Pyrazolobenzamides and derivatives as factor xa inhibitors
05/04/2006WO2006046758A1 Process for producing blocked isocyanate compound
05/04/2006WO2006045504A1 Process for the preparation of pyrazoles
05/04/2006US20060094881 Methods of preparing indazole compounds
05/04/2006US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
05/04/2006US20060094694 Heterocyclic compounds and thrombopoietin receptor activators
05/04/2006CA2582141A1 Process for the preparation of pyrazoles
05/03/2006EP1652842A1 Indazole derivatives
05/03/2006EP1651612A1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
05/03/2006EP1651611A2 Benzimidazole c-2 heterocycles as kinase inhibitors
05/03/2006EP1651602A2 Aryl heteroaromatic products, compositions comprising the same and use thereof
05/03/2006EP1651595A2 Ubiquitin ligase inhibitors
05/03/2006EP1651231A2 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
05/03/2006EP1651212A1 Thio-substituted phenbutazone compounds as anti-inflammatory, anti-viral and immunomodulatory agents
05/03/2006EP1572665B1 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors
05/03/2006EP1515955A4 Chemical process
05/03/2006EP1353904B9 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
05/03/2006EP1208091B1 Benzophenones as inhibitors of reverse transcriptase
05/03/2006CN1768061A Pyrazolo[1,5-a][1,3,5]triazine derivatives as cannabinoid receptor ligands
05/03/2006CN1768053A Pyrazole compounds.
05/03/2006CN1768052A Substituted pyrazole compounds
05/03/2006CN1768051A Substituted pyrazoles
05/03/2006CN1768043A 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders.
05/03/2006CN1768042A Process for producing acrylonitrile compound
05/03/2006CN1765886A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
05/02/2006US7038057 Alkylation, acylation
05/02/2006US7037931 CCK-1 receptor modulators
05/02/2006US7037930 3-arylphenyl sulfide derivative and insecticide and miticide
05/02/2006US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor
05/02/2006US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease